Hostname: page-component-76fb5796d-x4r87 Total loading time: 0 Render date: 2024-04-25T15:50:51.900Z Has data issue: false hasContentIssue false
  • English
  • Français

Vancomycin Use and Monitoring in Pediatric Patients in a Community Hospital

Published online by Cambridge University Press:  02 January 2015

Ozlem Kahyaoglu ,
Mustafa Akpinar ,
Brian Nolan ,
Susumu Inoue ,
George Zureikat  and
Ashir Kumar
Ozlem Kahyaoglu
Affiliation:
Hurley Medical Center Flint, Michigan
Mustafa Akpinar
Affiliation:
Hurley Medical Center Flint, Michigan
Brian Nolan
Affiliation:
Hurley Medical Center Flint, Michigan
Susumu Inoue
Affiliation:
Hurley Medical Center Flint, Michigan
George Zureikat
Affiliation:
Hurley Medical Center Flint, Michigan
Ashir Kumar
Affiliation:
Michigan State University Lansing, Michigan
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 19 , Issue 5 , May 1998 , pp. 299 - 301
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1998

References

REFERENCES

1. Rice, LB, Shlaes, DM. Vancomycin resistance in Enterococcus . Pediatr Clin North Am 1995;42:601–618.Google Scholar
2. Centers for Disease Control and Prevention. Recommendations for preventing the spread of vancomycin resistance, recommendations of the Hospital Infection Control Practice Advisory Committee. MMWR 1995;44(RR-12):1–13.Google Scholar
3. Sinkowitz, RL, Keyserling, H, Walker, TJ, Holland, J, Jarvis, WR. Epidemiology of vancomycin usage at a children's hospital, 1993 through 1995. Pediatr Infect Dis J 1997;16:485–489.Google Scholar
4. Pizzo, PH, Hathorn, JW, Heimenz, J, et al. A randomized trial comparing cef-tazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986;315:552–558.Google Scholar
5. Cantu, TG, Yamanaka-Yuen, NA, Leitman, PS. Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 194;18:533–543.Google Scholar